Form D · Other Health Care
Precision Medicine Group Holdings, Inc.
Bethesda, MD · CIK 0001854019
Offering snapshot reported Mar 30, 2021 · SEC filing
- Reported sold
- $35.2M Indefinite offering
- Investors reported
- 93 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2021 | Initial | $35,160,000 | No comparison | 93 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-393975
Source: Form D, filed Mar 30, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Charles T. Clark | Executive |
| Mark Clein | Director, Executive |
| Matthew De Zee | Executive |
| Jake Graetz | Executive |
| Christopher J. Hadley | Director |
| Matthew Hobart | Director |
| Julia Kahr | Director |
| Ethan Leder | Director, Executive |
| John B. Mariano, Jr. | Executive |
| Anushka Sunder | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2 Bethesda Metro Center, Suite 850
Bethesda, MD, 20814
Bethesda, MD, 20814